Current and new therapies for mucopolysaccharidoses
The mucopolysaccharidoses (MPSs) are a subset of lysosomal storage diseases caused by deficiencies in the enzymes required to metabolize glycosaminoglycans (GAGs), a group of extracellular heteropolysaccharides that play diverse roles in human physiology. As a result, GAGs accumulate in multiple tis...
Saved in:
Main Authors: | Monica Penon-Portmann (Author), David R. Blair (Author), Paul Harmatz (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
by: Simona Fecarotta, et al.
Published: (2018) -
The new frame for Mucopolysaccharidoses
by: Rossella Parini, et al.
Published: (2018) -
ENT and mucopolysaccharidoses
by: Pier Marco Bianchi, et al.
Published: (2018) -
Orthopaedic challenges for mucopolysaccharidoses
by: Andrea Borgo, et al.
Published: (2018) -
Newborn screening in mucopolysaccharidoses
by: Maria Alice Donati, et al.
Published: (2018)